Q32 Bio Inc. QTTB

8.77 (0.45) (4.88%) as of 25 Sep
Market cap
$282.8M
P/E
2.9×
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
1.43 — 0.00 0.00 0.00 0.00 0.00 0.00 — —
P/S ratio
0.00 — 0.00 21.49 5.93 191.98 523.74 120.06 — —
P/FCF ratio
0.00 — 0.00 0.00 0.00 0.00 0.00 0.00 — —
P/Operating CF
(6.61) — (0.35) (2.53) (6.62) (44.67) (33.14) (79.09) — —
P/B ratio
0.97 — 0.00 0.39 1.19 2.65 3.38 3.25 — —
Price to Tangible BV
0.97 — 0.00 0.39 1.19 2.65 3.38 3.25 — —
EV/Sales
(0.34) — (3.34) (23.88) 2.04 117.23 366.25 79.71 — —
EV/EBITDA
0.00 — 0.00 0.57 0.00 0.00 0.00 0.00 — —
EV/Operating CF
(0.07) — (1.19) 0.67 (0.63) (3.36) (6.68) (9.97) — —
EV/FCF
(0.08) — (1.19) 0.67 (0.62) (3.23) (5.39) (6.28) — —
Quick Ratio
4.26 4.74 1.82 7.75 9.05 9.60 21.20 9.54 14.63 1.79
Current Ratio
4.85 4.97 2.04 8.02 11.14 9.69 21.54 9.84 14.85 1.88
Net Debt/EBITDA
(2.21) 1.00 (0.39) 1.09 1.52 1.65 2.53 3.66 4.48 1.17
Debt/Assets
15.71% 13.70% 93.62% 12.90% 11.30% 5.86% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.23 2.23 (0.62) 0.17 0.14 0.08 0.00 0.00 0.00 0.00
Asset Turnover
0.70 0.00 (0.05) 0.01 0.14 0.01 0.01 0.03 0.00 0.00
Operating CF/Net income
(1.12) 1.42 0.35 22.71 1.15 0.73 0.88 0.77 (0.22) 1.05
Capex/Depreciation
12.26 (0.16) (0.01) 1.96 (0.26) (0.48) (3.46) (19.35) (2.86) (8.30)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
125.06% 53.86% 2,174.51% (2.88%) (52.38%) (56.63%) (45.69%) (70.84%) 121.55% 32.61%
ROA
38.70% (68.49%) (39.01%) (2.27%) (40.28%) (44.82%) (36.48%) (28.03%) (39.53%) (10.61%)
ROIC
308.43% 0.00% 0.00% (256.87%) (159.02%) 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
66.74% (71.48%) (327.92%) (3.14%) (54.12%) (55.02%) (35.00%) (23.67%) (23.82%) (106.37%)
Average Days of Receivables
0.00 — 0.00 0.00 0.00 0.00 0.00 0.00 — 0.00
Research and Development Expense of Revenue
35.65% 0.00% (477.06%) 3,065.80% 274.01% 3,715.47% 5,366.03% 900.94% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
32.90% 0.00% (148.47%) 1,188.84% 108.43% 1,205.51% 1,333.19% 325.07% 0.00% 0.00%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
9.78% 0.00% (21.47%) 406.92% 50.76% 490.30% 458.28% 49.29% 0.00% 0.00%
Graham Net Nets
0.86 — (23.71) 1.89 0.74 0.29 0.25 0.25 — —
Graham Number
13.35 — 1,347.28 0.00 0.00 0.00 0.00 0.00 — —
Earnings Yield
69.88% — (1,419.03%) (7.49%) (46.39%) (24.78%) (11.92%) (24.44%) — —
Free Cash Flow Yield
(65.18%) — (493.22%) (166.75%) (55.68%) (18.90%) (12.97%) (10.56%) — —
Revenue per Share
4.37 0.00 (19.05) 1.01 11.05 1.06 0.71 3.35 0.00 0.00
Operating CF per Share
(2.73) (7.26) (53.50) (35.61) (35.71) (36.96) (39.01) (26.81) 47.02 (80.27)
Capex per Share
0.57 (0.01) (0.01) (0.40) (0.78) (1.46) (9.32) (15.71) (14.21) (18.82)
Free Cash Flow per Share
(2.16) (7.27) (53.51) (36.02) (36.48) (38.42) (48.33) (42.52) 32.81 (99.09)
Cash per Share
3.93 8.36 73.38 54.84 50.71 85.18 112.05 135.27 940.92 107.78
Shareholders Equity per Share
3.42 0.61 (204.74) 55.77 55.19 76.78 110.39 123.69 713.41 70.96
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
3.42 0.61 (204.74) 55.77 55.19 76.78 110.39 123.69 713.41 70.96
Free Cash Flow
(26.54) (67.79) (18.68) (114.95) (112.15) (98.06) (113.19) (67.50) 4.52 (10.47)
Working Capital
43.70 65.41 14.61 158.44 174.68 196.91 254.20 199.17 122.74 5.61
Capital Expenditures
7.00 (0.07) 0.00 (1.28) (2.40) (3.73) (21.83) (24.94) (1.96) (1.99)
Net Current Asset Value
35.29 (4.78) (89.82) 130.52 149.84 151.82 214.52 158.95 92.38 5.27
EV/EBIT
0.13 — 0.00 0.57 0.00 0.00 0.00 0.00 — —
Capex to Sales
(0.13) 0.00 0.00 0.40 0.07 1.38 13.11 4.69 0.00 0.00
Net Profit Margin
55.49% 0.00% 808.04% (156.02%) (281.90%) (4,762.92%) (6,237.45%) (1,044.29%) 0.00% 0.00%
Price to Operating Income
0.00 — 0.00 0.00 0.00 0.00 0.00 0.00 — —
Other line items
Depreciation/Fixed assets
0.58 0.34 0.33 (0.61) 4.11 0.21 0.15 0.04 0.22 0.12
Cash ROIC
(34.52%) (71.74%) 1,133.46% (30.00%) (32.05%) (30.62%) (25.74%) (19.02%) 1.46% (55.26%)
Accounts Receivable Turnover
0.00 — 0.00 0.00 0.00 6.76 2.78 11.65 — 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
— — — 0.00 0.00 — — — 0.00 0.00
Average Days of Payables
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days of Inventory on Hand
— — — 0.00 0.00 — — — 0.00 0.00
Average Receivables
— — — — — 0.40 0.60 0.46 — 0.46
Average Payables
1.93 3.23 2.31 1.76 3.54 3.67 9.17 9.14 1.72 1.72
Average Assets
77.05 69.69 137.76 220.10 237.73 287.15 284.83 198.31 75.87 75.87
Average Common Equity
23.84 (88.62) (2.47) 173.81 182.82 227.25 227.43 78.45 (24.67) (24.67)

Fold the line items

Columns are period end dates